NASDAQ:RZLV • GB00BQH8G337
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for REZOLVE AI PLC (RZLV).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2026-01-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-12-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-12-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-10-02 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-10-02 | Roth Capital | Maintains | Buy -> Buy |
| 2025-10-02 | Maxim Group | Maintains | Buy -> Buy |
| 2025-10-02 | Northland Capital Markets | Maintains | Outperform -> Outperform |
| 2025-10-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-15 | Roth Capital | Reiterate | Buy -> Buy |
| 2025-09-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-01 | Alliance Global Partners | Initiate | Buy |
| 2025-06-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-01 | HC Wainwright & Co. | Initiate | Buy |
| 2025-03-19 | Roth MKM | Maintains | Buy -> Buy |
| 2025-01-16 | Maxim Group | Initiate | Buy |
| 2024-12-20 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-12-18 | Northland Capital Markets | Initiate | Outperform |
| 2024-12-10 | Roth MKM | Initiate | Buy |
| 2024-12-05 | Cantor Fitzgerald | Initiate | Overweight |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 187.8K | 41.32M 21,902.13% | 315.31M 663.09% | 500.83M 58.84% | |||
| EBITDA YoY % growth | -4.256M -44,697.89% | -2.547M 40.16% | -137.818M -5,311.61% | -28.714M 79.17% | 4.838M 116.85% | 34.603M 615.23% | |
| EBIT YoY % growth | -4.5M -857.45% | -2.789M 38.02% | -138.043M -4,849.37% | -45.059M 67.36% | -11.93M 73.52% | 8.857M 174.24% | |
| Operating Margin | N/A | N/A | -73,505.22% | -109.05% | -3.78% | 1.77% | |
| EPS YoY % growth | N/A | N/A | N/A | -0.27 -149.52% | -0.11 58.97% | -0.03 72.09% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.04 | 0.03 200.00% | -0.04 | -0.04 -16.67% | -0.02 50.00% | -0.02 -166.67% |
| Revenue Q2Q % growth | 10.209M | 27.378M 14,478.27% | 76.5M 29,900.00% | 33.826M 435.48% | 66.973M 556.02% | 74.46M 171.97% |
| EBITDA Q2Q % growth | -5.505M | -5.107M 96.29% | -6.222M 32.22% | -4.786M 84.50% | 463.08K 108.41% | 2.254M 144.13% |
| EBIT Q2Q % growth | -10.572M | -1.345M 99.03% | -11.73M -18.86% | -6.438M 80.14% | -5.045M 52.28% | -3.254M -141.85% |
All data in USD
12 analysts have analysed RZLV and the average price target is 11.48 USD. This implies a price increase of 318.8% is expected in the next year compared to the current price of 2.74.
The consensus EPS estimate for the next earnings of REZOLVE AI PLC (RZLV) is -0.04 USD and the consensus revenue estimate is 10.21M USD.
The expected long term growth rate for REZOLVE AI PLC (RZLV) is 1137.65%.